Drug Interactions between ixazomib and sars-cov-2 (covid-19) ad26 vaccine, recombinant
This report displays the potential drug interactions for the following 2 drugs:
- ixazomib
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
Interactions between your drugs
ixazomib SARS-CoV-2 (COVID-19) Ad26 vaccine, recombinant
Applies to: ixazomib and sars-cov-2 (covid-19) ad26 vaccine, recombinant
If you are currently being treated or have recently been treated with ixazomib, you should let your doctor know before receiving SARS-CoV-2 (COVID-19) Ad26 vaccine, recombinant. Depending on the dose and length of time you have been on ixazomib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of ixazomib therapy. If you have recently been vaccinated with SARS-CoV-2 (COVID-19) Ad26 vaccine, recombinant, your doctor may choose to postpone treatment with ixazomib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
ixazomib food
Applies to: ixazomib
Food may interfere with the absorption of ixazomib, which may lead to lower blood levels of the medication and possibly reduced effectiveness. You should take ixazomib at least 1 hour before or 2 hours after eating. On days when you take both ixazomib and dexamethasone, make sure you do not take them at the same time, since ixazomib should be taken on an empty stomach while dexamethasone should be taken with food to prevent irritation and injury to the stomach.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.